Severe Leukocyte Adhesion Deficiency-I (LAD-I) Lentiviral-Mediated Ex-Vivo Gene Therapy: Ongoing Phase 1/2 Study Results

被引：0
|
作者：
Booth, Claire [1 ]
Sevilla, Julian [2 ,3 ]
Lopez, Maria Chitty [4 ]
Almarza, Elena [5 ]
Zubicaray, Josune [2 ,3 ]
Chetty, Kritika [6 ]
Moore, Theodore [7 ]
Bueren, Juan [3 ,8 ]
Schwartz, Jonathan [4 ]
Kohn, Donald [9 ]
机构：
[1] UCL Great Ormond St Inst Child Hlth, Gene Therapy & Paediat Immunol, London, England
[2] Hosp Infantil Univ Nino Jesus HIUNJ, Fdn Invest Biomed, Madrid, Spain
[3] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
[4] Rocket Pharmaceut Inc, Cranbury, NJ USA
[5] Rocket Pharmaceut Inc, Proc Dev LVV, Cranbury, NJ USA
[6] UCL Great Ormond St Inst Child Hlth, London, England
[7] Univ Calif Los Angeles, Pediat Blood & Marrow Transplant Program, Los Angeles, CA USA
[8] Ctr Invest Energet Medioambient Tecnol CIEMAT, Hematopoiet Innovat Therapies Div, Madrid, Spain
[9] Univ Calif Los Angeles, UCLA Gene & Cell Therapy, Los Angeles, CA USA
来源：
CLINICAL IMMUNOLOGY | 2023年 / 250卷
关键词：
Gene Therapy; Primary Immundodeficiencies; Leukocyte Adhesion Deficiency-I;
D O I：
10.1016/j.clim.2023.109354
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
7
引用
收藏
页数：1
相关论文
共 45 条
  • [21] Changing the Natural History of Fanconi Anemia Complementation Group-A with Gene Therapy: Early Results of US Phase I Study of Lentiviral-Mediated Ex-Vivo FANCA Gene Insertion in Human Stem and Progenitor Cells
    Czechowicz, Agnieszka
    Rio, Paula
    Bueren, Juan E.
    Beard, Brian
    Nicoletti, Eileen
    Schwartz, Jonathan
    Soni, Sandeep
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S39 - S40
  • [22] Global phase 1 study results of lentiviral mediated gene therapy for severe pyruvate kinase deficiency
    Sevilla, J.
    Shah, A. J.
    Lorenzo, J. L. L.
    Navarro, S.
    Lanos, L.
    de Camino Gaisse, B. P.
    Sanchez, S.
    Zubicaray, J.
    Glader, B.
    Chien, M.
    Bustamante, O. Q.
    Zeini, M.
    Choi, G.
    Nicoletti, E.
    Rao, G. R.
    Roncarolo, M. G.
    Bueren, J. A.
    Schwartz, J. D.
    Segovia, J. C.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A4 - A4
  • [23] Global Phase 1 Study Results of Lentiviral Mediated Gene Therapy for Severe Pyruvate Kinase Deficiency
    Shah, Ami J.
    Lopez Lorenzo, Jose Luis
    Sevilla, Julian
    Navarro, Susana
    Llanos, Lucia
    de Camino Gaisse, Begona Perez
    Sanchez, Sol
    Zubicaray, Josune
    Glader, Bertil
    Chien, May
    Quintana Bustamante, Oscar
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri
    Roncarolo, Maria-Grazia
    Bueren, Juan A.
    Schwartz, Jonathan
    Carlos Segovia, Jose
    MOLECULAR THERAPY, 2023, 31 (04) : 118 - 119
  • [24] Interim Results from an Ongoing Global Phase 1 Study of Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency
    Lopez Lorenzo, J. L.
    Shah, A. J.
    Sevilla, J.
    Navarro, S.
    Llanos, L.
    de Camino Gaisse, B. Perez
    Sanchez, S.
    Zubicaray, J.
    Glader, B.
    Chien, M.
    Bustamante, O.
    Zeini, M.
    Choi, G.
    Nicoletti, E.
    Rao, G. R.
    Roncarolo, M. G.
    Bueren, J. A.
    Schwartz, J. D.
    Segovia, J. C.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A58 - A58
  • [25] Ex-Vivo Gene Therapy for Hurler Disease: Initial Results from a Phase I/II Clinical Study
    Gentner, Bernhard
    Bernardo, Maria Ester
    Zonari, Erika
    Tucci, Francesca
    Fumagalli, Francesca
    Redaelli, Daniela
    Acquati, Serena
    Silvani, Paolo
    Parini, Rossella
    La Marca, Giancarlo
    Ciceri, Fabio
    Naldini, Luigi
    Aiuti, Alessandro
    MOLECULAR THERAPY, 2019, 27 (04) : 1 - 2
  • [26] Phase I Study Protocol for Ex Vivo Lentiviral Gene Therapy for the Inherited Skin Disease, Netherton Syndrome
    Di, Wei-Li
    Mellerio, Jemima E.
    Bernadis, Catina
    Harper, John
    Abdul-Wahab, Alya
    Ghani, Sumera
    Chan, Lucas
    Martinez-Queipo, Magdalena
    Hara, Havinder
    McNicol, Anne-Marie
    Farzaneh, Farzin
    McGrath, John
    Thrasher, Adrian
    Qasim, Waseem
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2013, 24 (04) : 182 - 190
  • [27] Changing the Treatment Paradigm for Pyruvate Kinase Deficiency with Lentiviral Mediated Gene Therapy: Interim Results from an Ongoing Global Phase 1 Study
    Shah, A. J.
    Lopez Lorenzo, J. L.
    Navarro, S.
    Sevilla, J.
    Llanos, L.
    de Camino Gaisse, B. Perez
    Sanchez, S.
    Glader, B.
    Chien, M.
    Quintana Bustamante, O.
    Zeini, M.
    Choi, G.
    Nicoletti, E.
    Rao, G. R.
    Roncarolo, M. G.
    Bueren, J. A.
    Schwartz, J. D.
    Segovia, J. C.
    MOLECULAR THERAPY, 2022, 30 (04) : 170 - 170
  • [28] Changing the Natural History of Fanconi Anemia Complementation Group-A with Gene Therapy: Early Results of US Phase I Study of Lentiviral-Mediated Ex-VivoFANCA Gene Insertion in Human Stem and Progenitor Cells
    Czechowicz, Agnieszka
    Roncarolo, Maria Grazia
    Beard, Brian C.
    Law, Ken
    Nicoletti, Eileen
    Rio, Paula
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Soni, Sandeep
    BLOOD, 2019, 134
  • [29] Early Results of a Phase I/II Study of Gene Therapy for β-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-Vivo with a Lentiviral βAT87Q-Globin Vector
    Soni, Sandeep
    Thompson, Alexis A.
    Walters, Mark
    Leboulch, Philippe
    Cavazzana, Marina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S28 - S29
  • [30] Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: Interim Results of a Global Phase 1 Study for Adult and Pediatric Patients
    Shah, Ami J.
    Lopez Lorenzo, Jose Luis
    Navarro, Susana
    Sevilla, Julian
    Llanos, Lucia
    Perez de Camino Gaisse, Begona
    Sanchez, Sol
    Glader, Bert
    Chien, May
    Quintana Bustamante, Oscar
    Beard, Brian C.
    Law, Kenneth M.
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri R.
    Grazia Roncarolo, Maria
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Segovia, Jose C.
    BLOOD, 2021, 138
12345